Concepedia

E Till

ET

1

Publications

32

Citations

1

H-Index

2008

Active since

E Till is an author specializing in medicine, pharmacology, and molecular oncology.

Top concepts

Publications per year

2008–2008

1

Publications

1

A phase I study of AVE1642, a humanized monoclonal antibody IGF-1R (insulin like growth factor1 receptor) antagonist, in patients(pts) with advanced solid tumor(ST)

A. W. Tolcher, A. Patnaik, E Till et al. · Journal of Clinical Oncology · 2008 · 32 citations

, , +15

Rows per page

1–1 of 1